Role of Interleukin-I Super Family in Progression of Osteoarthritis


  • Experimental and Public Health Laboratory, Department of Zoology, University of Lucknow, Lucknow – 226007
  • Molecular Endocrinology Lab, Department of Zoology, University of Lucknow, Lucknow-226007
  • Department of Orthopaedics, King George Medical University, Lucknow – 226003
  • Molecular Endocrinology Lab, Department of Zoology, University of Lucknow, Lucknow – 226007
  • Department of Orthopedics, King George Medical University, Lucknow – 226003
  • Department of Orthopedics, King George Medical University, Lucknow – 226003
  • Experimental and Public Health Laboratory, Department of Zoology, University of Lucknow, Lucknow – 226007



Cytokine, IL-1 Family, Mode of Action, Osteoarthritis.


Osteoarthritis (OA) is considered as multifactorial disorder characterized by erosion of articular cartilage, tightening of joint space, subchondral bone remodelling and internal synovial inflammation. OA reduces joint function progressively as a person gets older. The most important group of the cytokines or chemokines are pre-dominantly involving in the early progression of the disease includes IL-1, IL-6, IL-18 and TNF-a, etc. IL-1 family of cytokines are known to be strongest stimulus for progressive synthesis of Matrix Metallo Proteinases (MMPs). Large number of immune cells, chondrocytes and endothelial cells potentially secrete IL-1 with diverse effect on number of diseases. This review highlights the association of IL-1 family cytokine in OA.


Metrics Loading ...


Akhtar, N., Rasheed, Z., Ramarnurthy, S., Anbazhagan, A. N., Voss, F. R. and Haqqi, T. M. (2010) "MicroRNA-27b regulates the expression of matrix 13 in human osteoarthritis chondrocytes", Arthritis Rheum, 62, 1361-1371. Crossref PMid:2013 1257 PMCid:PMC3 139404

Alaaeddine, N., Olee, T., Hashimoto, S., CreightonAchermann, L. and Lotz, M. (2001) "Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation". Arthritis Rheum, 44, 1633-1643. Crossref

Arliani, G., Astur, D. C., Yamada, R. K. F., Yamada, A. F., Miyashita, G. K., Mandelbaum, B. and Cohen. (2014) "Early osteoarthritis and reduced quality of life after retirement in former professional soccer players", Clinics (Sao Paulo), 69, 589-594. Crossref

Arnalich, F., Lopez-Maderuel, D., Codoceo, R., Lopez, J., Solis-Garrido, L. M., Capiscol, C., Fernandez-Capitan, C., Madero, R., Montiel, C. (2002) "Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis'', Clin Exp Immunol, 127, 331-336. Crossref

Banerjee, M. and Saxena, M. (2012) "Interleukin-1 (IL-1) family of cytokines: Role in type 2 Diabetes", Clinica Chimica Acta, 413, 1163-1170. Crossref

Barretoa, A. and Braunb T. R. (2016) "A method to induce Interleukin-1 Receptor Antagonist Protein from autologous whole blood", Cytokine, 81, 137-141. Crossref PMid:26994310

Bau, B., Gebhard, P. M., Haag, J., Knorr, T., Bartnik, E. and Aigner, T. (2002) "Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro", Arthritis Rheum, 46, 2648-2657. Crossref PMid:12384923

Bauge, C., Attia, J., Leclercq, S., Pujol, J. P., Galera, P. And Boumediene, K. (2008) "Interleukin-lbeta up-regulation of Smad7 via NF-kappaB activation in human chondrocytes': Arthritis & Rheumatology, 58, 221-226. Crossref PMid:18163503

Bijlsma, J. W. J., Berenbaum, F. And Lafeber, F. P. J. G. (2011) "Osteoarthritis: an update with relevance for clinical practice', The Lancet, 337, 2115-2126. Crossref

Boraschi, D. and Tagliabue, A. (2013) "The interleukin-1 receptor family", Seminars in Immunology, 25, 394-407. Crossref PMid:24246227

Carter, D. B., Deibe, M. R.Jr., Dunn, C. J., Tomich, C. S., Laborde, A. L., Slightom, J. L., Berger, A. E., Bienkowski, M. J., Sun, F. F. and McEwan, R. N. (1990) "Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein", Nature, 344, 633-638. Crossref PMid:2 139180

Choi, Y. S., Park, J. K., Kang, E. H., Lee, Y. K., Kim, T. K., Chung, J. H., Zimmerer, J. M., Carson, W. E., Song, W. Y. and Lee, Y. J. (2013) "Cytokine signalling-1 suppressor is inducible by IL-1 beta and inhibits the catabolic effects of IL-1 beta in chondrocytes: Its implication in the paradoxical joint-protective role of IL-1 beta", Arthritis Research & Therapy, 15, 191. Crossref PMid:24238405 PMCid:PMC3979110

Conti, B., Jahng, J. W., Tinti, C., Son, J. H. and Joh, T. H. (1997) "Induction of interferon-gamma inducing factor in the adrenal cortex", J Biol Chem, 272, 2035-2037. Crossref PMid:8999896

Dinarello, C. A. and Thompson, R. C. (1991) "Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro", Immunol Today, 12, 404-410. Crossref

Dinarello, C.A. (2011) "A clinical perspective of IL-β as the gatekeeper of inflammation': Eur J Immunol, 41, 1203-121 7. Crossref PMid:21523780

Dinarello, C. A. (1994) "The interleukin-1 family: 10 years of discovery", FASEB J, 8, 1314-1325. PMid:8001745

Fu, M., Huang, G., Zhang, Z., Liu, J., Zhang, Z., Huang, Z., Yu, B. and Meng, F. (2015) "Expression profile of long noncoding RNAs in cartilage from knee osteoarthritis patients", Osteoarthritis Cartilage, 23, 423-432. Crossref. PMid:25524778

Gay, N. J. and Keith, F. J. (1991) "Drosophila toll and IL-1 receptor", Nature, 351, 355-356. Crossref PMid: 1851964

Gordon, A., Kiss-Toth, E., Stockley, I., Eastell, R., and Wilkinson, M. J. (2008) "Polymorphisms in the interleukin1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplasty", Arthritis & Rheumatism, 58, 3157-3165. Crossref PMid:18821666

Granowits, E., Clark, B., Mantilla, J. and Dinarello, C. (1991) "Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin receptor", J Bio Chem, 266, 14147-14150.

Grover, S., Tandon, B., Mishra, R. and Aggarwal, A. (2006) "Interleukin-1 receptor antagonist gene polymorphism in patients with rheumatoid arthritis in India': Indian J. Med. Res, 123, 815-820. PMid:16885604

Guerne, P. A., Carson, D. A. and Lotz, M. (1990) "IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro", J Immunol, 144, 499-505. PMid:2104896

Hassett, A. L., Epel, E., Clauw, D. J, Harris, R. E., Harte, S. E., Kairys, A., Buyske, S. and Williams, D. A. (2012) "Pain is associated with short leukocyte telomere length in women with fibromyalgia': J Pain, 13, 959-969. Crossref PMid:23031395

Helmick, C. G., Felson, D. T., Lawrence, R. C., Gabriel, S., Hirsch, R., Kwoh, C. K., Liang, M. H., Kremers, H. M., Mayes, M. D., Merkel, P. A., Pillemer, S. R., Reveille, J. D. and Stone, J. H. (2008) "Estimates of the prevalence of arthritis and other rheumatic conditions in the United States': Arthritis Rheum, 58, 15-25. Crossref PMid:18163481

Kawai, T. and Akira, S. (2007) "TLR signalling': Seminars in Immunology, 19, 24-32. Crossref PMid: 17275323

Koshy, P. J., Lundy, C. J., Rowan, A. D., Porter, S., Edwards, D. R., Hogan, A, Clark, I. M. and Cawston, T. E.(2002) "The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: A time-course study using real-time quantitative reverse transcription-polymerase chain reaction", Arthritis and Rheum, 46, 961-967. Crossref PMid:11953973

Lark, M. W., Bayne, E. K., Flanagan, J., Harper, C. F., Hoerrner, L. A., Hutchinson, N. I., Singer, II., Donatelli, S. A., Weidner, J. R., Williams, H. R., Mumford, R. A. and Lohmander, L.S. (1997) Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritis, and rheumatoid joints. J Clin Invest, 100, 93-106. Crossref PMid:9202061 PMCid:PMC508169

Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H., Deyo, R. A., Gabriel, S., Hirsch, R., Hochberg, M. C., Hunder, G. G., Jordan, J. M., Katz, J. N., Kremers, H. M. and Wolfe, F. (2008) "Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II": Arthritis Rheum, 58, 26-35. Crossref PMid: 18 163497 PMCid:PMC3266664

Lee, A. S., Ellman, M. B., Yan, D., Kroin, J. S., Cole, B. J., Van Wijnen, A. J. and Im, H. J. (2013) "A current review of molecular mechanism regarding osteoarthritis and pain'', Gene, 527, 440-447. Crossref PMid:23830938 PMCid:PMC3745800

Lotz, M., Terkeltaub, R. and Villiger, P. M. (1992) "Cartilage and joint inflammation. Regulation of IL-8 expression by human articular chondrocytes", J Immunol, 148, 466-473. PMid: 1729366

Loughlin, J., Dowling, B., Mustafa, Z. and Chapman, K. (2002) 'Association of the Interleukin-1 Gene Cluster on Chromosome 2q13 with Knee Osteoarthritis", Arthritis & Rheumatism, 46, 1519-1527. Crossref PMid:12115182

Madry, H. and Cucchiarini, M. (2013) 'Advances and challenges in gene-based approaches for osteoarthritis", The Journal of Gene Medicine, 15, 343-55. Crossref PMid:24006099

Malfait, A.M., Lu,i R.Q., Ljiri, K., Komiya, S. and Tortorella, M. D. (2002) "Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritis cartilage", J Biol Chem, 227, 22201-22208. Crossref PMid:11956193

Martel-Pelletier, J., McCollum, R., DiBattista, J., Faure, M. P., Chin, J. A., Fournier, S., Sarfati, M. and Pelletier, J. P. (1992) "The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes: Identification as the type I receptor and analysis of binding kinetics and biologic function", Arthritis Rheum, 35, 530-540. Crossref

Mclntyre, K. W., Stepan, G. J., Kolinsky, K. D., Benjamin, W. R., Plocinski, J. M., Kaffka, K. L., Campen, C. C., Chizzonite, R. A. and Kilian, P. L. (1991) "Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro by IL-1 receptor antagonist and anti IL-1 receptor monoclonal antibody", J Exp Med, 173, 931-939. Crossref

Miyaki, S., Nakasa, T., Otsuki, S., Grogan, S. P., Higashiyama, R., Inoue, A., Kato, Y., Sato, T., Lotz, M. K. and Asahara, H. (2009) "MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses", Arthritis Rheum, 60, 2723-2730. Crossref PMCid:PMC2806094

Moos, V., Fickert, S., Muller, B., Weber, U. and Sieper, J. (1999) "Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage", J Rheumatol, 26,870-879. PMid:10229409

Nagase, H., and Kashiwagi, M., (2003) "Aggrecanases and cartilage matrix degradation", Arthritis Res Ther, 5, 94-103. Crossref PMid: 12718749

Prinz, M. and Hanisch, U. K., (1999) "Murine microglial cells produce and respond to interleukin-18'; J Neurochem, 72, 2215-2218. Crossref PMid:10217305

Richette, P., Corvol, M. and Bardin, T. (2003) "Estrogents, cartilage, and osteoarthritis", Joint Bone Spine, 70, 257-262. Crossref

Roman-Blas, J. A. and Jimenez, S. A. (2006) "NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis", Osteoarthritis Cartilage, 14, 839-48. Crossref PMid: 16730463

Sadouk, M. B., Pelletier, J. P., Tardif, G., Kiansa, K., Cloutier, J. M. and Martel-Pelletier, J. (1995) "Human synovial fibroblasts coexpress IL-1 receptor type I and type II mRNA: The increased level of the IL-1 receptor in osteoarthritic cells is related to an increased level of the type I receptor", Laboratory Investigation, 73, 347-55. PMid:7564267

Sims, J. E. (2002) "IL-1 and IL-18 receptor, and their extended family", Curr OpinImmunol, 14, 117-122. Crossref

Sommer, C. and Kress, M. (2004) "Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia", Neuroscience letters, 361, 184-187. Crossref PMid: 15135924

Stevenson, F. T., Turck, J., Locksley, R. M. and Lovett, D. H. (1997) "The N-terminal propiece of interleukin 1 alpha is a transforming nuclear oncoprotein", Proc Natl Acad Sci USA, 94, 508-13. Crossref

Swellam, M., Mahmoud, M.S., Samy, N. and Gamal, A. A. (2010) "Potential influence of interleukin-1 receptor antagonist gene polymorphism on knee osteoarthritis risk'', Disease Markers, 28, 299-305. Crossref PMid:20592454 PMCid:PMC3833698

Symons, J. A., Young, P. R. and Duff, G. W. (1995) "Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1β- precursor and loses affinity for IL-1 receptor antagonist", National Academy of Sciences of the United States of America, 92, 1714-1718. Crossref

Tsang, Y. T., Neelamegham, S., Hu, Y., Berg, E. L., Burns, A. R., Smith, C. W. and Simon, S. I. (1997) "Synergy between L-selectin signaling and chemotactic activation during neutrophil adhesion and transmigration", J Immunol, 159, 4566-4577. PMid:9379058

Verma, P. and Dalal, K. (2011) "ADAMTS-4 and ADAMTS-5: Key enzymes in osteoarthritis" Journal of Cellular Biochemistry, 112, 3507-35 14. Crossref PMid:21815191

Vigers, G. P., Anderson, L. J., Caffes, P. and Brandhuber, B. J. (1997) "Crystal structure of the type I interleukin-l receptor complexed with interleukin-1β", Nature, 386, 90-94. Crossref PMid:9062193

Villiger, P. M., Terkeltaub, R. and Lotz, M. (1992) "Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexarnethasone and retinoic acid", J Clin Invest, 90, 488-496. Crossref PMid:1365641 PMCid:PMC443 125

Weber, A., Wasiliew, P. and Kracht, M. (2010) "Interleukin-1 (IL-1) pathway", Sci Signal, 3. Crossref PMid:20086235

Wojdasiewicz, P., Poniatowski, L. A. and Szukiewicz, D. (2014) "The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis", Mediators of Inflammation, 2014, 1-19. Crossref PMid:24876674 PMCid:PMC4021678

Yuyan, N., Rui, B., Zhenqun, Z., Yishan, W., Daihe, L., Yong, W. Sun, C., Sun, L., Zhang, B., Jin, T. and Liu, W. (2017) ''IL1R1 gene polymorphisms are associated with knee osteoarthritis risk in the Chinese Han population", Oncotarget, 8, 4228-4233.




How to Cite

Kumar, A., Arshad, M., Singh, A., Jafri, A., Ali, S., Yadav, M., & Swaroop, S. (2017). Role of Interleukin-I Super Family in Progression of Osteoarthritis. Journal of Ecophysiology and Occupational Health, 17(1-2), 9–16.